Table 5.
Therapy during poststroke
| Treatments | mRS | P value | Recurrence | P value | ||
| Therapy during poststroke | Favourable | Unfavourable | Yes | No | ||
| Antiplatelet | 345 (70.7) | 62 (68.1) | 0.623 | 35 (76.1) | 372 (69.8) | 0.370 |
| Antihypertensive | 193 (69.4) | 30 (60.0) | 0.188 | 15 (60.0) | 208 (68.6) | 0.373 |
| Hypoglycaemic agents | 37 (31.6) | 9 (31.0) | 0.951 | 6 (42.9) | 40 (30.3) | 0.336 |
| Lipid lowering | 122 (45.9) | 25 (49.0) | 0.679 | 11 (45.8) | 136 (46.4) | 0.956 |
| Traditional Chinese medicine | 107 (21.9) | 24 (26.4) | 0.352 | 6 (13.0) | 125 (23.5) | 0.105 |
| Homocysteine-lowering therapy | 84 (61.8) | 7 (33.3) | 0.014 | 5 (45.5) | 86 (58.9) | 0.384 |
mRS, modified Rankin Scale.